The ␥-secretase complex catalyzes intramembrane proteolysis of a number of transmembrane proteins, including amyloid precursor protein, Notch, ErbB4, and E-cadherin. ␥-Secretase is known to contain four major protein constituents: presenilin (PS), nicastrin, Aph-1, and Pen-2, all of which are integral membrane proteins. There is increasing evidence that the formation of the complex and the stability of the individual components are tightly controlled in the cell, assuring correct composition of functional complexes. In this report, we investigate the topology, localization, and mechanism for destabilization of Pen-2 in relation to PS function. We show that PS1 regulates the subcellular localization of Pen-2: in the absence of PS, Pen-2 is sequestered in the endoplasmic reticulum (ER) and not transported to post-ER compartments, where the mature ␥-secretase complexes reside. PS deficiency also leads to destabilization of Pen-2, which is alleviated by proteasome inhibitors. In keeping with this, we show that Pen-2, which adopts a hairpin structure with the N and C termini facing the luminal space, is ubiquitylated prior to degradation and presumably retrotranslocated from the ER to the cytoplasm. Collectively, our data suggest that failure to become incorporated into the ␥-secretase complex leads to degradation of Pen-2 through the ER-associated degradation-proteasome pathway.
An increasing number of type 1 membrane proteins have been shown to undergo complex proteolytic processing through a mechanism referred to as regulated intramembrane proteolysis (RIP) 1 (1) . In many cases, RIP is associated with the sequential processing of proteins on the luminal side of the membrane and within the transmembrane domain and usually results in the release of a cytosolic signaling portion of the protein. Among the RIP-processed proteins are amyloid precursor protein (APP) (2), Notch (3, 4) , CD44 (5, 6), ErbB-4 (7, 8) , and E-cadherin (9) . For these proteins, the intramembrane cleavage event is critically dependent on a high molecular protein assembly known as the ␥-secretase complex, which displays enzyme kinetics characteristic of an aspartyl protease. The ␥-secretase complex is currently believed to consist of presenilin (PS), nicastrin, Aph-1, and Pen-2 proteins (10 -14) . PS is a multipass membrane-spanning protein that, after endoproteolysis into an N-and C-terminal fragment (NTF and CTF, respectively), forms a stable, and presumably active, noncovalent heterodimer. PS has been proposed to provide the active site of the ␥-secretase complex through two conserved transmembrane aspartate residues (15) . Supporting evidence for the hypothesis that PS is an aspartyl protease comes from the identification of PS being a member of an aspartyl protease family consisting of polytopic transmembrane proteins having the conserved motif GXGD (X ϭ variable amino acid) containing the C-terminal critical aspartate residue (16) .
Less is known about the other proteins in the complex, but it is becoming increasingly evident that the formation of the complex and the stabilization of the individual components is a coordinated and complex process. For example, PS is required for the proper maturation and cell surface localization of nicastrin (17, 18) and, conversely, ablation of nicastrin affects PS stability (19, 17) . In addition, knockdown of either Pen-2 or Aph-1 levels results in destabilization of mature PS and nicastrin proteins (20, 21) .
Pen-2 was originally characterized in Caenorhabditis elegans in a genetic screen for the PS-controlled step in Notch signaling (12) . Recent studies have shown that Pen-2 interacts with PS, nicastrin, and Aph-1 and that its expression is required for PS endoproteolysis and ␥-secretase complex formation (21, 22) . However, several important questions regarding Pen-2 remain to be addressed, including how its subcellular localization and stability is regulated in relation to PS expression. In this report we demonstrate that PS1 controls the subcellular localization of Pen-2, such that Pen-2 is sequestered in the ER in the absence of PS. We also show that Pen-2 is ubiquitylated prior to degradation in a proteasome-depend-ent manner and presumably retrotranslocated from the ER to the cytoplasm. Finally, and in accordance with a recent report (23) , we demonstrate that Pen-2 is oriented as an inverted hairpin within the membrane bilayer, where the N and C termini are facing the luminal space.
MATERIALS AND METHODS
Antibodies-The polyclonal antibody UD-1 was raised against the N-terminal residues ERVSNEEKLNL of Pen-2. Antibodies used for immunoprecipitations, immunoblotting, and immunocytochemical experiments were anti-FLAG M2 (Sigma), anti-nicastrin (Sigma), anti-HA 12CA5 (Berkeley Antibodies Inc.), anti-PS1 loop MAB 5232 (Chemicon, Temecula, CA), anti-ubiquitin (Dako), anti-calnexin (a kind gift from Dr. Ralf Pettersson), anti-GM130 (BD Transduction Laboratories), anti-APP CTF C1/6.1, and NT1 (a kind gift from Dr. Paul Mathews) , and anti-PS1 Ab14 (generously provided by Sam Gandy).
DNA Constructs-A cDNA encoding human Pen-2 was amplified by PCR using Pfu DNA polymerase and cloned into the pDONR201 plasmid of the Gateway system (Invitrogen). The construct was further cloned into destination vectors using Gateway recombinase reactions to generate expression constructs encoding Pen-2 with an N-terminal FLAG tag and a C-terminal HA tag, respectively. In, addition, Pen-2-HA was subcloned using the Gateway system to generate pCAG-Pen-2-HA-IRES-Puro. Pen-2 constructs carrying glycosylation acceptor sites (Asn-Ser-Thr) at positions 2-4 (NN), 8 -10 (N) , and 93-95 (C) were generated by silent mutations using a PCR-based mutagenesis protocol. For the same purpose, PCR was used to generate a construct with an extra Asn and Ser residue inserted between residues 47 and 48 of Pen-2 (loop region). The following pairs of oligonucleotides were used: (NNglyc-Pen-2 forward: 5Ј-GCAGGCTCTATGAACTCGACGCGAGTGTCC-AATGAGG-3Ј, NN-glyc-Pen-2 reverse: 5Ј-CCTCATTGGACACTCGCG-TCGAGTTCATAGAGCCTGC-3Ј,); (N-glyc-Pen-2 forward: 5Ј-GAGCGA-GTGTCCAATTCGACGAAATTGAACCTGTGC-3Ј, N-glyc-Pen-2 reverse: 5Ј-GCACAGGTTCAATTTCGTCGAATTGGACACTCGCTC-3Ј); (loop-glyc-Pen-2 forward: 5Ј-CCTTGTCCCAGCCTACACAAACAGCAC-AGAACAGAGCCAAATC-3Ј, loop-glyc-Pen-2 reverse: 5Ј-GATTTGGCT-CTGTTCTGTGCTGTTTGTGTAGGCTGGGACAAGG-3Ј); (C-glycPen-2 forward: 5Ј-CTTGGGGACTACCTCAACTCGACCATACCCCTG-GGCACC-3Ј, C-glyc-Pen-2 reverse: 5Ј-GGTGCCCAGGGGTATGGTCG-AGTTGAGGTAGTCCCCAAG-3Ј). The Pen-2 K54R mutant was generated by the same method using the following pairs of oligonucleotides: (Pen-2 K54R forward: 5Ј-AGAACAGAGCCAAATCCGGGGCTATGTC-TGGCGCT-3Ј, Pen-2 K54R reverse: 5Ј-AGCGCCAGACATAGCCCCGG-ATTTGGCTCTGTTCT-3Ј). All PCR-based mutagenesis was carried out according to the QuikChange mutagenesis protocol (Stratagene). All constructs were verified by sequencing using an ABI377 automated sequencer (PerkinElmer Life Sciences).
Cell Culturing and Transfection Experiments-CHOPro5 and 293T cells were cultured in alpha minimal essential medium and Dulbecco's modified Eagle's medium, respectively, supplemented with 10% fetal bovine serum, penicillin, and streptomycin. Blastocyst-derived ES-cells, deficient in PS1 and PS2, BD8 cells, were cultured as previously described (24) . BD8 cells stably expressing PS1, BD8:PS1 cells, were cultured as BD8 cells with additional puromycin (1 g/ml). Transient transfections were performed in 6-well tissue culture plates for coimmunoprecipitations, 24-well tissue culture plates for deglycosylation experiments, and 10-cm dishes for ubiquitylation experiments. All cells were plated at a suitable density the day before transfection. CHOPro5 and BD8 cells were transfected according to the LipofectAMINE Plus method (Invitrogen). For each well of the 6-and 24-well tissue culture dishes, 1 g and 300 ng, respectively, of the indicated DNA constructs were included in the transfection mixture. 293T cells were transfected according to the FuGENE method. For each 10-cm plate 4 g of the indicated DNA constructs were used in the transfection reactions. BD8 cells stably expressing Pen-2 HA, BD8:Pen-2-HA, were generated by transient transfection of BD8 cells with pCAG-Pen-2-HA-IRES-Puro. The transfected cells were cultured in medium supplemented with puromycin (1 g/ml) for 1 week. Single puromycin-resistant colonies were expanded and analyzed for Pen-2-HA expression.
Immunoprecipitation and Ubiquitylation Experiments-Co-immunoprecipitation experiments were carried out 24 h post transfection. The cells were lysed in IP buffer (25 mM Hepes, pH 7.5, 150 mM KCl, 2 mM EGTA, 1% CHAPS, and protease inhibitor mixture (Roche Applied Science)) and incubated with the indicated primary antibodies over night at 4°C. Protein A/G-agarose (Amersham Biosciences) was added, and the reactions were left for another hour at 4°C. The immunoprecipitates were washed twice in IP buffer and twice in PBS prior to SDS-PAGE (10 -20% Tris-Tricine gels (Invitrogen)) and Western blot analysis.
Ubiquitylation experiments were conducted with transiently transfected 293T cells and with BD8:Pen-2-HA cells, which were exposed to vehicle only (Me 2 SO) or MG-132 (5 and 50 M, respectively) for 8 h prior to analysis. The cells were then lysed in 300 l of lysis buffer (1% SDS, 50 mM Tris, 100 mM NaCl plus protease inhibitors, and 10 mM Nethylmaleimide) and boiled for 5 min. The lysates were then diluted with 1200 l of TN buffer (50 mM Tris, 100 mM NaCl, 0.5% sodium deoxycholate, 1% Triton X-100, 1% bovine serum albumin plus protease inhibitors, and 10 mM N-ethylmaleimide) and the incubations were left on ice for 10 min. Immunoprecipitations were carried out for 1 h at 4°C with anti-FLAG (293T lysates) and anti-HA (BD8:Pen-2-HA lysates) antibodies, followed by 1-h incubation at 4°C in the presence of Sepharose G. After several washes in TN buffer, the immunoprecipitates were analyzed with immunoblotting for ubiquitinated proteins using anti-HA and anti-ubiquitin antibodies.
Deglycosylation Assay and Proteinase K Protection Assay-The deglycosylation assay was performed 24 h post transfection in a buffer consisting of 10 mM Hepes, pH 7.4, 250 mM sucrose, 200 mM sodium citrate, 100 mM NaCl, 10 mM KCl, 5 mM EDTA plus EGTA, 1.5 mM MgCl 2 , 0.3% SDS, 0.6% ␤-mercaptoethanol, and protease inhibitors. Endoglycosidase H (Endo H, Roche Applied Science) and peptide Nglycosidase F (Roche Applied Science) were added where indicated. The deglycosylation reactions were incubated at 37°C for 16 h and then analyzed by Western blot.
The proteinase K protection assay was carried out 24 h post transfection at 4°C. CHOPro5 cells transfected with Pen-2-HA encoding cDNA were exposed to proteinase K (100 g/ml) for 30 min and subsequently analyzed by 10 -20% Tris-Tricine (Invitrogen) SDS-PAGE and immunoblotting.
Subcellular Fractionation Studies-BD8 and BD8:PS1 cells grown in 15 cm plates to near confluency were used for all fractionation experiments. The cells were homogenized in ice-cold homogenization buffer (130 mM KCl, 25 mM NaCl, 1 mM EGTA, 25 mM Tris, pH 7.4) supplemented with protease inhibitors using a Dounce homogenizer. Lysates were cleared by centrifugation at 1,000 ϫ g for 10 min. The supernatant was overlaid onto the top of a step gradient consisting of 1 ml each of 30, 25, 20, 15, 12.5, 10, 7.5, and 5% (v/v) Iodixanol (OptiPrep reagent, Axis-Shield PoC AS) in homogenization buffer. After a 3-h centrifugation at 126,000 ϫ g (SW40 rotor, Beckman), 12 fractions were collected from the top of the gradient. Fractions were analyzed for the presence of Pen-2, nicastrin, and PS1 NTF, as well as protein markers of subcellular organelles by immunoblotting using 4 -12% Bis-Tris gels (Invitrogen). The intensity of all immunoreactive bands was determined using the public domain NIH Image program (developed at the U.S. National Institutes of Health and available on the Internet at rsb.info.nih.gov/nih-image/).
Pharmacological Inhibition-BD8 cells were treated with MG-132 (Calbiochem), lactacystin (Sigma), ALLN (Sigma), calpeptin (Calbiochem), or chloroquine (Sigma) for inhibition of proteasomal, calpain, or lysosomal activity, respectively. BD8:PS1 cells were treated with MG-132 and chloroquine. MG-132 was used at 2.5 and 5 M; lactacystin at 2.5 and 5.0 M; ALLN at 2.5 M; calpeptin at 0.5, 1.0, 2.5, 5.0, and 10 g/ml; and chloroquine at 10, 20, 50, 100, and 200 M. After an 8-h incubation period, cells were harvested and lysed in whole cell extract buffer (20 mM HEPES, pH 7.8, 0.42 M NaCl, 0.5% Nonidet P-40, 25% glycerol, 0.2 mM EDTA, 1.5 mM MgCl 2 , 1 mM dithiothreitol) supplemented with protease inhibitors. For analysis of endogenous levels of Pen-2, protein concentration in the lysates were determined by the Bradford method, and equal amounts of protein were loaded and resolved on 10 -20% Tris-Tricine gels (Invitrogen), with subsequent detection of Pen-2 by immunoblotting. For the immunocytochemical experiments, cells were cultured for 8 h in the presence of 10 M MG-132, 10 M lactacystin, 10 g/ml calpeptin, or 100 M chloroquine before analysis.
Expression Studies in the Presence of Cycloheximide-BD8 and BD: PS1 cells were plated in 6-well tissue-culture plates and transfected with expression constructs encoding Pen-2-HA, Pen-2-HA (K54R), or Pen-2-HA (K11R/K17A/K54R), from herein called Pen-2-HA (K0), the day before cycloheximide treatment. Transfected cells were exposed to 50 g/ml cycloheximide for 0, 0.5, 1, 2, 4, and 8 h and then harvested in whole cell extract buffer. Protein levels were determined by the Bradford method and an equal amount of protein from each cell extract was then further analyzed for Pen-2 expression by immunoblotting using the anti-HA antibody. The same blots were stained with anti-␤-actin antibodies to control for equal amount of protein loaded.
Immunocytochemistry-BD8, BD8:Pen-2-HA, and 293T cells were seeded out on glass slides and in some experiments transfected with PS1 or PEN-2-HA encoding constructs. Cells were either treated with empty vehicle (Me 2 SO) or with different pharmacological agents for 8 h prior to analysis. The cells were then fixed with 4% formaldehyde in PBS (pH 7.4) at 4°C for 15 min, blocked for 1 h at room temperature in blocking solution (PBS supplemented with 5% bovine serum albumin, 10% goat serum, and 0.3% Triton X-100), and stained with primary antibodies in blocking solution at 4°C over night. Following extensive washing in PBS, the cells were incubated with Alexa 546-and 488-conjugated goat anti-mouse and goat anti-rabbit antibodies (Molecular Probes) and DAPI in blocking solution in darkness for 40 min. After thorough washing in PBS, the cells were mounted in ProLong mounting medium (Molecular Probes). Immunoreactivity was visualized in a Zeiss Axioplan2 microscope and photographed using a Zeiss Axiocam. The subcellular localization of Pen-2 in the presence or absence of PS1 was determined using a Bio-Rad Radiance confocal microscopy unit. Images were assembled using PhotoShop (Adobe).
RESULTS

␥-Secretase Complex Incorporation of Endogenous and Ectopically Expressed Pen-2-We first wanted to establish how
Pen-2 associates with other known components of the ␥-secretase complex. To this end, we raised an antibody (UD-1) against the N-terminal domain of Pen-2, which specifically labeled Pen-2 ( Fig. 1A ). In accordance with data from others (21), we found that antibodies raised against both the N-terminal part of PS1 and the C-terminal part of nicastrin were able to co-immunoprecipitate Pen-2 in non-transfected CHO cells, suggesting that Pen-2 interacts with PS1 and nicastrin when expressed at physiological expression levels (Fig. 1B) . Under these experimental conditions, it was however not possible to immunoprecipitate endogenous Pen-2 with the UD-1 antibody, and we were consequently unsuccessful in co-precipitating either PS1 or nicastrin. In contrast, if detergents known to disrupt ␥-secretase complexes were included in the immunoprecipitation buffer, robust amounts of Pen-2 were pulled down with the UD-1 antibody (Fig. 1C ). These observations are consistent with a previous study using an antibody raised against a similar peptide antigen in Pen-2 (21) and suggest that the UD-1 antibody interacts with a Pen-2 epitope that is hidden in the assembled complex.
To study Pen-2 incorporation into ␥-secretase complexes we therefore made use of N-terminally FLAG-tagged Pen-2 constructs, transiently transfected into CHO cells. Immunoprecipitation with an anti-FLAG antibody pulled down transiently expressed FLAG-Pen-2 ( Fig. 1D ) and co-immunoprecipitated endogenous PS1 and nicastrin. The CHO cells used here contain detectable levels of full-length endogenous PS1, and it is worth noting that both full-length PS1 and PS1 NTF co-precipitated with FLAG-Pen-2 and that FLAG-Pen-2 appeared to preferentially associate with the mature form of nicastrin (Fig.  1D) . To determine the influence of PS1 on Pen-2 incorporation into ␥-secretase complexes, we transiently transfected BD8 cells, which lack both PS1 and PS2, or BD8 cells stably expressing PS1 (BD8:PS1), with FLAG-Pen-2. In BD8 cells, only minute amounts of FLAG-Pen-2 could be immunoprecipitated (Fig. 1E) . In contrast, FLAG-Pen-2 was efficiently immunoprecipitated in BD8:PS1 cells and mature nicastrin as well as full-length PS1 and PS1 NTF were co-immunoprecipitated (Fig. 1E) . Collectively, these results suggest that endogenous Pen-2 is part of the ␥-secretase complex and that PS1 stabilizes Pen-2 and facilitates its interaction with nicastrin.
Subcellular Localization of Pen-2-The expression and maturation of the components of the ␥-secretase complex are coordinately regulated. For instance, PS is required for the proper maturation and cell surface localization of nicastrin (16, 17) , and ablation of nicastrin affects PS stability (18, 19) . In the next series of experiments we addressed whether PS1, in addition to its role in the stabilization of Pen-2, also affected its subcellular localization. We therefore analyzed the subcellular localization of Pen-2 in BD8 and BD8:PS1 cells using discontinuous 5-30% iodixanol gradients. In BD8 cells, Pen-2 immunoreactivity was found in fractions that are positive for calnexin, suggesting that endogenous Pen-2 is localized in ERenriched fractions in the absence of PS ( Fig. 2A, upper panel) . In BD8 cells, the Pen-2-positive fractions are also enriched for nicastrin. Because it has previously been shown that, in the absence of PS, nicastrin does not exit the ER (17) , this further corroborates the notion that Pen-2 is retained in the ER in the absence of PS. In the BD8:PS1 cells expressing PS1, a significant amount of Pen-2 was found in lighter, non-ER-and nonGolgi-enriched fractions ( Fig. 2A, lower panel) . These fractions also contained PS1 NTF and nicastrin, the latter almost exclusively in the form of the mature molecule (Fig. 2, A and B) . Retention of Pen-2 in the ER in the absence of PS was further supported by immunocytochemical localization of Pen-2. We generated BD8 cells stably expressing Pen-2-HA and examined the intracellular localization of Pen-2-HA in the presence and absence of transiently transfected PS1. In the absence of PS1, Pen-2-HA showed an ER-like staining and co-localized with the ER marker calnexin, whereas in the presence of PS1, Pen-2 HA showed a broader expression pattern and only partially colocalized with calnexin (Fig. 2C) . Consequently, the subcellular localization of Pen-2 is dependent on PS1: in the presence of PS1, Pen-2 is trafficked to compartments that have previously been shown to contain other components of the mature ␥-secretase complex. Combined with the results shown in Fig. 1D , these data suggest that PS1 and Pen-2 interact early in the secretory pathway and that they remain associated during ␥-secretase complex assembly, maturation, and trafficking.
Proteasomal Degradation of Pen-2-To learn more about how Pen-2 is destabilized in the absence of PS (Figs. 1E and 2), we determined whether Pen-2 is degraded via the lysosomal or proteasomal pathways in the absence of PS1. BD8 and BD8: PS1 cells were incubated with increasing concentrations of either the lysosomotropic agent chloroquine or the general and more specific proteasome inhibitors MG-132 and lactacystin, respectively. It appears that Pen-2 is not degraded in the lysosome, because chloroquine treatment did not stabilize Pen-2 in the absence of PS, whereas the same treatment stabilized APP-CTF, in accordance with previous data (25) (Fig. 3, A-C) . A calpain inhibitor, calpeptin, did not affect the stability of Pen-2, whereas it stabilized APP-CTF, consistent with previous reports (26) (Fig. 3D) . In contrast, all three proteasome inhibitors, MG-132, lactacystin, and ALLN, stabilized Pen-2 to a considerable extent (Fig. 3B) as determined by Western blot analysis. This suggests that Pen-2 is degraded by the proteasome in the absence of PS, and to corroborate this notion we performed immunocytochemical analysis and determined the staining intensity of Pen-2 after treatment with chloroquine, MG-132, or lactacystin. In BD8:Pen-2-HA cells cultured in the presence of MG-132 or lactacystin, expression of Pen-2-HA was notably enhanced, whereas no difference in staining intensity compared with control could be observed when chloroquine was added (Fig. 3E) . Collectively, these experiments clearly indicate that Pen-2 is subjected to proteasomal degradation in the absence of PS expression.
Based on our findings in BD8 cells, we hypothesized that PS needs to be present in non-limiting amounts to rescue Pen-2 from proteasomal degradation. To test this hypothesis, we created a situation where Pen-2 should be in excess over PS by transfecting 293T cells with N-terminally FLAG-tagged Pen-2, followed by treatment with MG-132 or Me 2 SO (control). Again, we noticed an increase in Pen-2 levels in cells treated with MG-132 (data not shown), showing that Pen-2 is degraded by the proteasome when PS, and possibly also other members of the ␥-secretase complex, are present in limiting amounts.
To determine whether this proteasomal degradation was preceded by ubiquitylation of Pen-2, 293T cells were transiently transfected with N-terminally FLAG-tagged Pen-2 and HA-tagged ubiquitin (27) . Immunoprecipitation with an anti-FLAG antibody was followed by immunoblotting using an anti-HA antibody. Under these conditions, a significant fraction of Pen-2 was ubiquitylated (Fig. 4A) . We were also able to demonstrate ubiquitylation of Pen-2-HA by endogenous ubiquitin after immunoprecipitation of Pen-2-HA from BD8:Pen-2-HA cells and immunoblotting for ubiquitin (Fig. 4B) .
Membrane Topology of Pen-2-We next wished to further explore how Pen-2 is degraded in the cell. Because lysine residues are targets for addition of ubiquitin, it was necessary to first establish the topology of Pen-2 in the membrane, to learn which of the three lysine residues (positions 11, 17, and 54) are facing the cytoplasm and the ER lumen, respectively. Pen-2 is composed of hydrophilic N-and C-terminal regions and two hydrophobic domains, which are linked by a hydrophilic loop. Based on these data, Pen-2 could adopt alternate hairpin topologies where either the N and C termini, or the loop region, would face the cytoplasmic side of the membrane (Fig. 5A ). We used a N-glycosylation scanning approach (28) to determine the membrane topology of Pen-2. Asn-Ser-Thr (NST) tri-peptide glycosylation acceptor sites were introduced into the N-and C-terminal domains and the hydrophilic loop region between the two hydrophobic domains, in a HA-tagged Pen-2 construct (Fig. 5B) . CHO cells were transfected with these glycosylation acceptor site mutants, and lysates were immunoblotted with an anti-HA antibody. The Pen-2 construct containing an NST site in the C-terminal domain was fully glycosylated indicating that the Pen-2 C terminus is located on the luminal side of the membrane bilayer (Fig. 5B) . In contrast, only a small fraction of the Pen-2 construct containing an NST site in the N-terminal domain showed a shift in electrophoretic mobility, suggesting that only a minor amount of this molecule was glycosylated (Fig. 5, B and C). Treatment with Endo-H and peptide Nglycosidase F removed the slower migrating Pen-2 species, indicating that the construct having an N-terminal NST site indeed is partially glycosylated (Fig. 5D) . No difference in electrophoretic mobility compared with the wild type molecule was observed with the construct carrying the NST site in the loop showing that both overexpressed and endogenous Pen-2 can be detected by UD-1. B, in untransfected CHOPro5 cells, endogenous Pen-2 coimmunoprecipitated with PS1 and nicastrin using antibodies Ab14 and anti-nicastrin (Sigma), respectively. C, untransfected CHOPro5 cells were subjected to immunoprecipitation with the UD-1 antibody. Pen-2 could not be immunoprecipitated under conditions keeping the ␥-secretase complex intact. In contrast, endogenous Pen-2 could successfully be immunoprecipitated in the presence of 1% Nonidet P-40 and 0.5% Triton X-100. D, N-terminally FLAG-tagged Pen-2 was transfected into CHOPro5 cells and immunoprecipitated with the anti-FLAG M2 antibody. Immunoprecipitates were analyzed for PS1, nicastrin, and FLAGPen-2 by immunoblotting with antibodies Ab14, anti-nicastrin, and anti-FLAG M2, respectively. Note that both the PS1 NTF and fulllength proteins co-precipitate with FLAG-Pen-2 (upper panel) and that the mature form of nicastrin co-precipitates with FLAG-Pen-2 (middle panel). E, PS-deficient BD8 cells and BD8 cells stably expressing PS1 (BD8:PS1) were transfected with FLAG-Pen-2. Cells were subjected to immunoprecipitation with the anti-FLAG M2 antibody and analyzed for PS1, nicastrin, and FLAG-Pen-2 by immunoblotting using antibodies NT1, anti-nicastrin, and anti-FLAG M2, respectively. Note that nicastrin mainly occurs in its immature form in BD8 cells, whereas it exists predominantly in its mature form in the BD8:PS1 cells. Note also that FLAG-Pen-2 is highly unstable in the BD8 cells and requires a very long exposure of the immunoblot to enable detection. In BD8:PS1 cells immunoprecipitated with the anti-nicastrin antibody, full-length PS1 and PS1 NTF are pulled down, as determined by immunoblotting with the NT1 antibody.
FIG. 1. Pen-2 co-immunoprecipitates with members of the ␥-secretase complex.
A, characterization of antibody UD-1, which recognizes endogenous Pen-2. An immunoblot of untransfected and Pen-2 transfected CHOPro5 cells using the antibody UD-1 raised against the N-terminal domain of Pen-2 is shown. The UD-1 antibody recognized a protein of the expected size of Pen-2, whereas no immunoreactivity was detected with pre-immune sera. The immunoreactivity was stronger in Pen-2-transfected cells than in untransfected cells,
FIG. 2. Endogenous Pen-2 distributes differently in the presence and absence of PS1 expression.
A, BD8 cells and BD8:PS1 cells were subjected to iodixanol density gradient fractionation (5-30%), and the distribution of Pen-2, nicastrin, PS1, and different organelle markers were analyzed by immunoblotting. Pen-2, nicastrin, and PS1 were detected using antibodies UD-1, anti-nicastrin, and NT1, respectively. ER-and Golgi-enriched fractions were identified with antibodies raised against calnexin and GM-130, respectively. Note that in the absence of PS1 expression (BD8 cells), Pen-2 is exclusively present in fractions that show positive staining for immature nicastrin and the ER-marker calnexin. B, the intensity of the immunoreactive bands in A was quantified using the NIH Image program and plotted as arbitrary units versus fraction number. Note the peak of Pen-2-HA immunoreactive signal in fraction 3 of BD8:PS1 cells (lower panel), which coincides with peak levels of PS1 NTF and mature nicastrin, but which is absent in fraction 3 of PS-deficient BD8 cells (upper panel). C, BD8:Pen-2-HA cells (upper four panels) and BD8:Pen-2-HA cells transiently transfected with a PS1 construct (lower four panels) were analyzed by immunocytochemistry and confocal microscopy using anti-HA antibodies to visualize Pen-2-HA (red), anti-calnexin to label the ER compartment (green), and DAPI to label cell nuclei (blue). Arrows denote Pen-2-HA positive staining, and arrowheads show that it is restricted to, and overlaps with, the staining for calnexin (yellow). Note the enhanced intensity and broader expression pattern of Pen-2-HA in the presence of PS1 and that it only partially overlaps with the staining for calnexin. region (Fig. 5C ). These data suggest that the N-and C-terminal domains of Pen-2 are susceptible to glycosylation and thus exposed to the luminal side of the membrane.
To further resolve this issue, CHO cells were transiently transfected with C-terminally HA-tagged Pen-2, and fragment patterns following proteinase K treatment were monitored by immunoblotting using the UD-1 and anti-HA antibodies. Treatment of cell lysates with proteinase K resulted in a protected 7-kDa C-terminal HA-reactive species, and a protected 5-kDa UD-1-reactive species (Fig. 5E) . Thus, both termini are located in the luminal compartment, demonstrating unequivocally that Pen-2 adopts a hairpin topology in biological membranes with the N and C termini facing the luminal space (Fig. 5A) . During the preparation of this report, Crystal et al. (23) published data on the topology of Pen-2, which are in accordance with these results.
Ubiquitylation and Retranslocation of Pen-2 prior to Degradation-Ubiquitylation occurs preferentially in the cytosol on lysine residues (29). As discussed above, Pen-2 contains only three lysine residues, which could be targets for the ligation of ubiquitin residues. Two of the lysines are located in the Nterminal domain (positions 11 and 17), and one is located in the hydrophilic loop of the protein (position 54). Based on the membrane topology of Pen-2, only the lysine in position 54 would be accessible to cytosolic ubiquitin conjugation if this occurs while the protein is still embedded within the ER membrane. To gain further insight into the mechanism of Pen-2 regulation, we next examined the effect of the lysine residues in Pen-2 on protein stability. We generated mutant Pen-2 expression constructs in which lysine in position 54 had been mutated to arginine (Pen-2 (K54R)) or where all lysines had been mutated (Pen-2(K0)). We found that Pen-2-HA (K54R), when transiently transfected into BD8 cells, had a considerably longer half-life compared with wild-type Pen-2-HA, suggesting that . No increase in Pen-2 stability was detected when inhibiting calpain (upper panel). In the lower panel an immunoblot using the monoclonal C1/6.1 antibody for APP-CTF is shown as a control for the effect of calpeptin. APP-CTF has been shown to accumulate in calpeptin-treated cells. E, BD8:Pen-2HA cells were cultured in the presence of Me 2 SO, chloroquine, calpeptin, MG-132, or lactacystin for 8 h. The cells were then analyzed by immunocytochemistry to visualize Pen-2-HA using anti-HA antibodies (red). DAPI was used to visualize nuclei (blue). Note that Pen-2-HA is only stabilized in the presence of the proteasomal inhibitors MG-132 and lactacystin. the lysine in position 54 is important for Pen-2 stability and may be a target for Pen-2 ubiquitylation (Fig. 6 A) . Interestingly, the Lys-54 residue is conserved from Drosophila helanogaster to humans and may thus be a conserved target for ubiquitylation of Pen-2 molecules that fail to incorporate into ␥-secretase complexes. Unfortunately, it turned out that exchanging all lysine residues in Pen-2 resulted either in a proteolytic cleavage event (when all lysines were mutated to arginines, data not shown) or undetectable levels when expressed in BD8 cells (Fig. 6A) . Most probably the substitution of all lysine residues results in a major conformational change and misfolding of Pen-2, which targets the mutant Pen-2 for degradation.
Having established the importance of the cytoplasmic lysine for Pen-2 stability, we examined if this construct could be ubiquitylated. Interestingly, the FLAG-Pen-2 (K54R) mutant retained the ability to become ubiquitylated in 293 cells, indicating that ubiquitin ligation also occurs on the lysine residues normally exposed to the luminal side of the membrane (Fig. 6,  B and C) . These data strongly suggest that Pen-2 thus must be released from the ER to the cytoplasm prior to ubiquitylation, to expose the lysine residues in position 11 and 17 to an E3 ubiquitin ligase. To address this further, we investigated whether the Pen-2 protein was retrotranslocated from the ER to the cytoplasm in cultured cells. We transiently transfected HA-tagged Pen-2 into 293T cells, thus creating a situation where PS will be present in limiting amounts as compared with the level of Pen-2, and treated the cells with MG-132 or Me 2 SO (control). Cells were permeabilized and stained with an anti-HA antibody. In Me 2 SO-treated cells, immunoreactivity showed a typical ER-Golgi staining (Fig. 7) . In contrast, in cells treated with MG-132, the Pen-2 immunoreactivity pattern was strikingly different. Staining was not confined to only ER-Golgi but observed throughout the cell in the cytoplasm, but most intensity was seen in the perinuclear area. A shift to similar intracellular distribution was observed also in Pen-2-HA (K54R)-expressing cells after MG-132 treatment (Fig. 7) . Taken together, this supports the view that Pen-2 is first retrotranslocated to the cytoplasm and then degraded by the proteasome.
DISCUSSION
The ␥-secretase complex is composed of at least four components: PS, nicastrin, Aph-1, and Pen-2. The understanding of the mechanisms of assembly and stability of these four proteins is only now emerging. Here we investigated the PS1-dependent intracellular localization and stability of Pen-2.
The formation and stabilization of the ␥-secretase complex are processes that are likely to be intricately linked and precisely controlled. It has been established that removal of one protein affects the stability of some of the other proteins, but the mechanism for the loss of stability is not known. Here, we show that the levels of Pen-2 protein are strongly reduced in PS-deficient cells (Figs. 1-3) , which is in accordance with two recent reports (21, 22) . We demonstrate that this is a result of ubiquitylation and proteasome-mediated and not lysosome-mediated degradation: MG-132, lactacystin, and ALLN but not chloroquine increased Pen-2 levels in BD8 cells. Ubiquitylation and proteasome-mediated degradation are responsible for removal of many proteins (30) and may operate on other proteins in the ␥-secretase complex, including PS1. Support for this notion comes from the observation that PS1 levels are strongly reduced in the absence of nicastrin or Aph-1 and that PS can be ubiquitylated by the mammalian Sel-10 E3 ubiquitin ligase (31) , which also ubiquitylates Notch (27) .
Pen-2 degradation is probably a result of ubiquitylation and proteasome-mediated degradation. Ubiquitylation was directly demonstrated by immunoprecipitation of Pen-2 followed by immunoblotting for endogenous ubiquitin. Proteasome-mediated degradation, rather than lysosome-mediated degradation, was demonstrated by the fact that MG-132, lactacystin, and ALLN but not chloroquine stabilized Pen-2. The ubiquitylation of Pen-2 appears to be complex. Mutation of the only lysine residue facing the cytoplasm (K54R) resulted in a considerably prolonged half-life of Pen-2, which indicates that this lysine residue is ubiquitylated. On the other hand, Pen-2 (K54R) is still ubiquitylated, arguing that also the lysine residues on the luminal side are ubiquitylated, although stability problems precluded a mutational analysis of lysine residues 11 and 17. We demonstrate that PS affects not only the stability of Pen-2, but also its intracellular localization. Subcellular fractionation and immunocytochemical analysis reveal that Pen-2 is predominantly confined to an ER-like compartment in the absence of PS. In PS1-expressing cells, Pen-2 localizes to fractions containing proteins expressed in ER and post-ER compartments that also were positive for PS1 NTF and mature nicastrin, suggesting that the mature ␥-secretase complex is present in these fractions as shown previously by others (22) .
Pen-2 degradation is probably triggered by the dysfunction in intracellular trafficking. Retention in the ER has been shown to be the cause for degradation of proteins. It therefore FIG. 4 . Pen-2 is subjected to ubiquitylation. A, 293T cells were co-transfected with constructs encoding FLAG-tagged Pen-2 and HAtagged ubiquitin and then cultured in the presence or absence of 5 M MG-132 for 8 h. Lysates were immunoprecipitated using anti-FLAG M2 antibodies followed by Western blot analyzes using either anti-HA or anti-FLAG antibodies. Pen-2 is indicated by an arrowhead and ubiquitylated Pen-2 species are indicated by arrows. B, BD8:Pen-2-HA cells were cultured in the presence or absence of 50 M MG-132 for 8 h. Cell lysates were prepared and subjected to immunoprecipitation using anti-HA antibodies followed by immunoblotting using anti-ubiquitin and anti-HA antibodies.
seems plausible that retention of Pen-2 in the ER is the cause for the observed increase in Pen-2 degradation in PS-deficient cells. Many proteins that are located in the ER are destined for degradation and disposed of by a mechanism referred to as the ER-associated degradation (ERAD)-proteasome pathway (32) . Here, proteins are first retrotranslocated from the ER to the cytoplasm where they are targeted through covalent attachment of ubiquitin molecules, which, in turn, triggers degradation by the proteolytic machinery of the proteasome. As discussed above, the ubiquitylation data for Pen-2 indicate ubiquitylation on lysine residues on both the cytoplasmic and luminal sides. Ubiquitylation on the luminal side is in accordance with ERAD-mediated degradation. This notion is supported by the observation that in cells, where Pen-2 is present in excess over PS, Pen-2 is largely localized to the cytoplasm after exposure to MG-132. This indicates that Pen-2 is retrotranslocated from the ER to the cytoplasm, where it accumulates when the proteasome is inactivated by MG-132.
How Pen-2 interacts with and depends on the other components in the ␥-secretase complex is a vital link to elucidating ␥-secretase function. We show that Pen-2 is co-immunoprecipitated by PS and nicastrin, in agreement with recent publications (13, 21, 22) . It is worth noting that immunoprecipitation with immunotagged Pen-2 pulled down both the full-length PS1 and the PS1 N-terminal fragment, generated as a result of PS endoproteolysis. This is in contrast to a report by Luo et al. (22) where Pen-2 was proposed to preferentially interact with full-length PS but in accordance with data from Steiner et al. (21) , who show an interaction with full-length PS and PS NTF. Interestingly, it was not possible to immunoprecipitate endogenous Pen-2 using the UD-1 antibody under conditions preserving the integrity of the ␥-secretase complex. Similar findings have been reported by Steiner and coworkers (21) , and it may indicate that Pen-2 is deeply embedded in the mature ␥-secretase complex resulting in masking of the N-terminal UD-1 epitope. If this is the case, it follows that the majority of endogenous Pen-2 is incorporated into complexes, since Pen-2 could only be brought down under conditions disassembling the functional ␥-secretase complex unit.
Taken together, our findings demonstrate that Pen-2 is sequestered in the ER, ubiquitylated and degraded in the absence of PS, most likely involving the ERAD-proteasome FIG. 5 . Membrane topology of Pen-2. A, schematic illustration of the Pen-2 protein. The Pen-2 protein contains three hydrophilic and two hydrophobic domains (upper panel) that presumably give rise to a hairpin structure within the membrane (lower panel). The two topological models proposed for Pen-2 are outlined in the lower panel. To the left is Pen-2 with its N and C termini in the cytoplasm and the loop region in the lumen. To the right is the alternative model with the N and C termini in the lumen and the loop region in the cytosol. B, schematic drawing of the different glycosylation acceptor sites-mutants used are shown. Asn-Ser-Thr tripeptide sites were introduced in the Nand C-terminal and loop domains, respectively, of Pen-2 carrying a C-terminal HA-tag. Shown is an immunoblot from transfected CHOPro5 cells using the monoclonal anti-HA antibody 12CA5. Note the shift in electrophoretic mobility resulting from glycosylation of C-glyc-Pen-2-HA and the partial shift of N-glyc-Pen-2-HA. Open circles indicate the glycosylated form of the proteins. C, an additional construct with a glycosylation site was generated at the N-terminal end of Pen-2-HA (NN-glyc-Pen-2-HA). Note that NN-glyc-Pen-2-HA is glycosylated to a greater extent than N-glyc-Pen-2-HA, as revealed by Western blot analyzes of transiently transfected CHOPro5 cells. This difference is probably due to the increased distance of the glycosylation acceptor site from the membrane boundary. D, CHOPro5 cells, transiently transfected with N-glyc-Pen-2-HA and C-glyc-Pen-2-HA, respectively, were treated with the deglycosidases Endo H and N-glycosidase F. Both Endo H and N-glycosidase F treatment generated species that migrated with the wild type molecule, as revealed by Western blot analyzes. Open circles indicate the glycosylated form of the proteins. E, a proteinase K protection assay was performed on CHOPro5 cells transiently transfected with a Pen-2-HA construct. Transfected cells were treated with Proteinase K in the presence and absence of Triton X-100, and cell extracts were subsequently prepared and analyzed with Western blot using anti-HA and UD-1 antibodies. Cells treated with Triton X-100 have the same appearance as untreated cells, whereas proteinase Ktreated cells show a partially degraded Pen-2 protein where a C-terminal fragment can be detected by the anti-HA antibody (upper panel) and an N-terminal fragment can be detected by UD-1 (lower panel). In cells treated with Triton X-100 and proteinase K, Pen-2 was fully degraded. These data suggest that the N and C termini of Pen-2 are facing the luminal side of the membrane and thus protected from proteinase K degradation in the absence of detergent.
pathway. These data provide a framework for future studies aimed at determining how the ␥-secretase complex is assembled and how components are eliminated when assembly fails. FIG. 6 . Pen-2 stability and ubiquitylation is strictly dependent on the integrity of lysine residues. A, schematic drawing displaying the membrane topology of Pen-2. The locations of the three lysine residues in Pen-2 are indicated. BD8 cells were transiently transfected with constructs encoding wild-type Pen-2-HA, Pen-2-HA (K54R), or Pen-2-HA (K0). The day after transfection, transfectants were exposed to 50 g/ml cycloheximide for the indicated time-points. The expression levels of the Pen-2-HA constructs were analyzed by Western blot using anti-HA antibodies. The same blots were hybridized with anti-␤-actin antibodies to normalize for the amount of protein loaded. B, the intensity of the immunoreactive signals corresponding to the Pen-2-HA protein species in A was quantified with the program NIH Image, and the data obtained were plotted as relative intensity versus time. Note the increased stability of Pen-2-HA (K54R) compared with wt Pen-2-HA. C, 293T cells were transiently co-transfected with DNA constructs encoding ubiquitin-HA and either FLAG-Pen-2 or FLAG-Pen-2 (K54R) and then exposed to Me 2 SO (vehicle) or MG-132 (5 M) for 8 h. Lysates were immunoprecipitated using anti-FLAG M2 antibodies followed by Western blot analyzes using either anti-HA or anti-FLAG antibodies. Pen-2 is indicated by an arrowhead, and ubiquitylated Pen-2 species are indicated by arrows. 
